Jean-Philippe Spano Selected Research

Jean-Philippe Spano Research Topics

Disease

68	Neoplasms (Cancer) 04/2024 - 08/2002
19	Breast Neoplasms (Breast Cancer) 10/2023 - 08/2002
8	Melanoma (Melanoma, Malignant) 10/2022 - 08/2006
8	Carcinogenesis 10/2014 - 05/2004
7	Renal Cell Carcinoma (Grawitz Tumor) 11/2023 - 10/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 09/2004
7	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2007
7	Colorectal Neoplasms (Colorectal Cancer) 10/2018 - 05/2005
6	Carcinoma (Carcinomatosis) 08/2022 - 05/2004
5	Infections 11/2023 - 05/2005
5	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2005
5	Acquired Immunodeficiency Syndrome (AIDS) 11/2014 - 02/2002
4	COVID-19 03/2023 - 01/2020
4	Opportunistic Infections (Opportunistic Infection) 02/2022 - 01/2004
4	Brain Neoplasms (Brain Tumor) 01/2019 - 05/2012
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 10/2009
3	Hemorrhage 07/2023 - 04/2020
3	Disease Progression 01/2022 - 04/2010
3	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2020 - 02/2002
2	Chronic Disease (Chronic Diseases) 03/2023 - 01/2020
2	Thrombosis (Thrombus) 02/2023 - 04/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 08/2022 - 12/2021
2	Immune Reconstitution Inflammatory Syndrome 02/2022 - 11/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 01/2019
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 11/2005
2	Renal Insufficiency (Renal Failure) 12/2021 - 03/2012
2	Rectal Neoplasms (Rectal Cancer) 01/2020 - 02/2003
2	Anus Neoplasms (Anal Cancer) 11/2014 - 10/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2012 - 06/2008
2	Anemia 01/2008 - 05/2005
1	Liver Failure 12/2023
1	Chronic Hepatitis B 12/2023
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2023
1	Neuroendocrine Carcinoma 06/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2023
1	Squamous Cell Carcinoma of Head and Neck 10/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2022

Drug/Important Bio-Agent (IBA)

11	Immune Checkpoint InhibitorsIBA 04/2024 - 12/2018
9	Biomarkers (Surrogate Marker)IBA 08/2016 - 01/2005
6	Trastuzumab (Herceptin)FDA Link 10/2023 - 12/2010
6	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2006
5	Hormones (Hormone)IBA 01/2019 - 12/2004
5	Long Noncoding RNAIBA 01/2017 - 10/2014
5	EnzymesIBA 10/2009 - 07/2006
4	Lapatinib (GW572016)FDA Link 10/2023 - 12/2010
4	Tyrosine Kinase InhibitorsIBA 02/2023 - 01/2005
4	NivolumabIBA 01/2022 - 04/2017
4	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 01/2005
4	Aromatase InhibitorsIBA 01/2019 - 01/2004
4	Bevacizumab (Avastin)FDA Link 10/2018 - 01/2011
4	ChromatinIBA 01/2017 - 09/2004
4	AnthracyclinesIBA 11/2014 - 08/2002
4	Gemcitabine FDA Link 09/2012 - 08/2002
3	Antineoplastic Agents (Antineoplastics)IBA 04/2024 - 10/2009
3	VaccinesIBA 11/2023 - 01/2022
3	AnticoagulantsIBA 07/2023 - 04/2020
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2004
3	Monoclonal AntibodiesIBA 01/2021 - 01/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 08/2005
3	Docetaxel (Taxotere)FDA Link 01/2011 - 01/2005
3	CreatinineIBA 12/2010 - 01/2009
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2006 - 05/2004
2	AntibodiesIBA 12/2023 - 03/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2023 - 04/2007
2	pembrolizumabIBA 08/2022 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 08/2016 - 01/2015
2	human ERBB2 proteinIBA 06/2015 - 06/2012
2	Estrogen ReceptorsIBA 10/2014 - 01/2004
2	Axitinib (AG 013736)IBA 08/2012 - 06/2008
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2012 - 06/2008
2	Anti-Retroviral Agents (Antiretroviral Agents)IBA 10/2009 - 01/2006
2	ImmunosorbentsIBA 05/2009 - 08/2006
2	Tamoxifen FDA LinkGeneric 02/2009 - 12/2004
2	Celecoxib (Celebrex)FDA Link 05/2004 - 05/2004
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2004 - 05/2004
2	rofecoxib (Vioxx)FDA Link 05/2004 - 05/2004
1	Staphylococcal Protein A (Protein A)IBA 11/2023
1	Ado-Trastuzumab EmtansineIBA 10/2023
1	Fluorouracil (Carac)FDA LinkGeneric 06/2023
1	PlatinumIBA 06/2023
1	Messenger RNA (mRNA)IBA 03/2023
1	COVID-19 VaccinesIBA 03/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2023
1	Death Domain ReceptorsIBA 10/2022
1	utomilumabIBA 10/2022

Therapy/Procedure

36	Therapeutics 11/2023 - 01/2004
23	Drug Therapy (Chemotherapy) 12/2023 - 02/2003
6	Immunotherapy 11/2023 - 04/2010
5	Radiotherapy 05/2014 - 02/2003
4	Highly Active Antiretroviral Therapy (HAART) 11/2015 - 01/2006
3	Adjuvant Chemotherapy 01/2020 - 02/2009
2	Neoadjuvant Therapy 01/2020 - 01/2019
2	Precision Medicine 12/2018 - 06/2013
2	Castration 09/2017 - 07/2016
2	Drug Tapering 12/2010 - 10/2009
1	Molecular Targeted Therapy 02/2024
1	Aftercare (After-Treatment) 12/2023